FDAnews
www.fdanews.com/articles/132339-nhs-reforms-could-see-patients-miss-out-on-drugs-for-alzheimer-8217-s-parkinson-8217-s

NHS Reforms Could See Patients Miss Out on Drugs for Alzheimer’s, Parkinson’s

December 2, 2010
[Eli Lilly] is threatening to delay the introduction of groundbreaking treatment for Alzheimer’s, Parkinson’s and schizophrenia in response to the Government’s planned NHS reforms.
The Telegraph